Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
Journalists
Submit Release
January 24, 2009
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Websites.
 
Close Move
All Press Releases for November 11, 2008 Subscribe to this News Feed    
 

New Treatment Options for Seasonal Affective Disorder, from Harvard Mental Health Letter

Bright white light therapy has been used to treat seasonal affective disorder (SAD) for more than 20 years. Although it remains a mainstay of treatment, in the past few years researchers have investigated ways to improve and refine light therapy, reports the November 2008 issue of the Harvard Mental Health Letter.

Boston, MA (Vocus/PRWEB ) November 11, 2008 -- Bright white light therapy has been used to treat seasonal affective disorder (SAD) for more than 20 years. Although it remains a mainstay of treatment, in the past few years researchers have investigated ways to improve and refine light therapy, reports the November 2008 issue of the Harvard Mental Health Letter.

Improvements are necessary for three reasons. First, light therapy doesn't work for everyone. Studies have reported that 50% to 80% of patients achieve complete relief and that remission may depend upon carefully individualized timing of light exposure. Second, dosing remains a major question. The recommendation for 30 minutes of daily exposure to 10,000 lux is based on average response to white light. Finally, side effects, while mild for many patients, may be more of a concern for others.

Dr. Michael Miller, editor in chief of the Harvard Mental Health Letter, notes that investigations are now under way to see if changing the timing or type of light therapy might improve response or reduce side effects. Some areas of study:

Better timing. Researchers reported that remission from SAD was twice as likely if light therapy was precisely calibrated to melatonin rhythms--which may vary by several hours from one individual to the next.

Dawn simulation. In this variation, a preset light device turns on before a patient awakens. Light intensity increases gradually over a period of 90 minutes. Although studies so far have been small, they have also been promising.

Blue light. Studies have found that cells in the retina are particularly sensitive to blue light, suggesting that this wavelength may powerfully affect circadian rhythms. Researchers are investigating whether blue light might provide the same benefit as white light but with less exposure time.

For a supplementary video, go online to www.health.harvard.edu/137.

Also in this issue:

  • Treating "first-episode" schizophrenia
  • Positive emotions to resolve disputes
  • The undecided voter

The Harvard Mental Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $24 per year. Subscribe at www.health.harvard.edu/mental or by calling 877-649-9457 (toll-free).

Media: Contact Raquel Schott at Raquel_Schott @ hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.

Harvard Health Publications
Contact: Raquel Schott
Raquel_Schott @ hms.harvard.edu
617-432-5781

# # #

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1Mb3ZlLUNyYXMtU2luZy1UaGlyLVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Raquel Schott
Harvard Health Publications
617-432-5781
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2009, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright